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Abstract
Background: The concept of specifying positional information in the adult cardiovascular system
is largely unexplored. While the Hox transcriptional regulators have to be viewed as excellent
candidates for assuming such a role, little is known about their presumptive cardiovascular control
functions and in vivo expression patterns.
Results: We demonstrate that conventional reporter gene analysis in transgenic mice is a useful
approach for defining highly complex Hox expression patterns in the adult vascular network as
exemplified by our lacZ  reporter gene models for Hoxa3  and  Hoxc11. These mice revealed
expression in subsets of vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) located
in distinct regions of the vasculature that roughly correspond to the embryonic expression domains
of the two genes. These reporter gene patterns were validated as authentic indicators of
endogenous gene expression by immunolabeling and PCR analysis. Furthermore, we show that
persistent reporter gene expression in cultured cells derived from vessel explants facilitates in vitro
characterization of phenotypic properties as exemplified by the differential response of Hoxc11-
lacZ-positive versus-negative cells in migration assays and to serum.
Conclusion: The data support a conceptual model of Hox-specified positional identities in adult
blood vessels, which is of likely relevance for understanding the mechanisms underlying regional
physiological diversities in the cardiovascular system. The data also demonstrate that conventional
Hox reporter gene mice are useful tools for visualizing complex Hox expression patterns in the
vascular network that might be unattainable otherwise. Finally, these mice are a resource for the
isolation and phenotypic characterization of specific subpopulations of vascular cells marked by
distinct Hox expression profiles.
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Background
The Hox transcriptional regulators are known to play a
critical role in establishing positional identities during
embryonic patterning [1], whereas in postnatal and adult
tissues, their functions are largely subject to speculation
[2]. This also pertains to the adult cardiovascular system,
although Hox genes are considered prime candidates for
determining phenotypic characteristics of vascular
smooth muscle cells (VSMCs) and endothelial cells (ECs)
during vasculogenesis and vascular remodeling both
under normal (e.g. wound healing, menstrual cycle) and
pathologic conditions (e.g. cancer-related angiogenesis,
atherosclerosis) [3]. A prerequisite for defining these roles
and underlying molecular mechanisms is information
about Hox expression patterns in adult vasculature in vivo,
which is currently scarcely available.
Considering the documented expression of various mem-
bers of this gene family in ECs and VSMCs [3], the near-
void of data concerning phenotypic changes in the cardi-
ovascular system of the numerous Hox gene-targeted and
transgenic mice is surprising. A notable exception is the
Hoxa3 gene-targeted mice, which exhibit a range of cardi-
ovascular defects [4-6], although a definition of the
molecular mechanisms underlying these defects was
essentially precluded due to lack of information about the
cardiovascular  Hoxa3  expression pattern, both in the
embryo and the adult. Perhaps of equal relevance is that
in the fruit fly Drosophila melanogaster the Hox gene abdA is
required for specifying cell identity in a posterior section
of the Drosophila  dorsal vessel, which is functionally
equivalent to the vertebrate heart [7].
Since these seminal observations with Hoxa3 and abdA in
mice and flies, respectively, a series of studies has shown
differential expression of Hox genes in ECs of different ori-
gin with respect to species and vessel type. For example, 8
of the 10 human HOXB genes were found expressed in
cultured umbilical vein ECs and this expression could be
modulated by vascular signaling molecules including tis-
sue plasminogen activator (TPA), and vascular endothe-
lial growth factor (VEGF) [8]. Most of the studies
involving endothelial Hox expression suggest a role in the
regulation of angiogenesis, i.e. the formation of new
blood vessels and microvasculature associated either with
normal developmental and physiological processes such
as mammary gland development and wound healing or
with pathological conditions such as tumorigenesis [8-
16].
Evidence for Hox expression in VSMCs was initially pro-
vided by showing Hoxa2 expression in VSMCs of embry-
onic vessels leading from the heart, in embryonic
cardiomyocytes, and in adult aortic VSMCs [17]; this was
facilitated by the isolation of a Hoxa2-specific cDNA from
a rat aorta-derived cDNA library. Additional VSMC-spe-
cific  Hox  cDNAs  (HOXA5, HOXA11, HOXB1, HOXB7,
and HOXC9) were isolated from fetal and adult human
VSMC cDNA libraries by using degenerate primers corre-
sponding to a highly conserved subregion of the home-
obox for screening [18]. Although providing more direct
evidence for in vivo expression of any of the corresponding
genes in fetal or adult aorta remained elusive in that study,
the potential relevance of these data was underscored in a
separate study showing scattered expression of HOXB7 in
media and neointima adjacent to calcification in human
atherosclerotic plaques [19]. To assess whether this might
reflect a role in directing immature cells towards either
osteoblastic or VSMC differentiation, HOXB7 was overex-
pressed in multipotent C3H10T1/2 cells that are capable
of differentiating into VSMCs, as well as osteogenic and
chondrogenic lineages. The results showed 3.5-fold
increase in proliferation and induction of VSMC-like mor-
phology, thus suggesting a role for HOXB7 in the expan-
sion of immature cell populations or dedifferentiation of
mature cells [19]. Of relevance in this context is the appar-
ent VSMC phenotype-dependent expression of HOXB7
and HOXC9 as evidenced by preferential expression in
cultured fetal versus adult VSMCs, a result that might indi-
cate a role for Hox genes in the control of VSMC-diversity
[18].
Although the activity patterns in different cardiovascular
lineages suggest potentially significant roles for Hox genes
in cardiovascular patterning and remodeling, nearly none
of these have been defined in vivo. Perhaps one of the
most confounding factors is an inherent difficulty in
defining gene expression patterns in a structurally and
physiologically diverse organ system branched through-
out the entire body. To overcome this obstacle, we used
lacZ reporter gene analysis in transgenic mice to obtain an
approximate global view of the postnatal and adult vascu-
lar expression patterns of two Hox  genes,  Hoxa3  and
Hoxc11. The data indicate distinct regionally restricted
zones of expression that roughly correspond to the dispa-
rate embryonic expression domains of the two genes.
These results support a role for Hox genes in specifying
and maintaining positional identities of VSMCs and ECs
in the adult vasculature.
Materials and methods
Cloning of Hoxa3-lacZ
A segment of genomic DNA of 11,473 base pairs (bp)
located directly upstream of the Hoxa3 translational start
codon was fused to E.coli lacZ derived from plasmid
pCH110 (Amersham Pharmacia). The Hoxa3  fragment
was derived from mouse genomic BAC clone RP24-
353A14 (Children's Research Institute, Oakland, CA) and
extended from the NruI restriction half-site located just 2
bp upstream of the Hoxa3 translational start codon [20] toBMC Developmental Biology 2008, 8:93 http://www.biomedcentral.com/1471-213X/8/93
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the BamHI site at position -11,473 relative to the transla-
tional start. Hoxa3-lacZ  was cloned in a pBluescript
(Promega) -derived vector termed pSafyre [21] and
released by Spe1  and  Not1  restriction enzymes for the
preparation of transgenic mice. Transgenic lacZ reporter
studies showed previously that sequences located
upstream of the Hoxa3 coding region contain both tran-
scriptional promoter and enhancer functions capable of
reconstructing the main aspects of endogenous Hoxa3
expression in E8.5-E9.5 mouse embryos (Hoxa3 reporter
gene analysis: [22]; endogenous Hoxa3 expression: [22-
24]).
Transgenic mice
A Hoxc11-lacZ transgenic line carrying the LZc11-S con-
struct was reported previously [25]. LZc11-S contained a
10 kb genomic fragment including the Hoxc11 transcrip-
tion unit in addition to 2 kb and 5 kb of Hoxc11 upstream
and downstream flanking sequences, respectively, as well
as E.coli lacZ fused in frame to first exon coding sequences
[25]; LZc11-S consistently reproduced endogenous
Hoxc11 expression pattern in E11.5 – E13.5 embryos (n =
3 founders, including 2 transgenic lines). One of the
LZc11-S lines has been designated TG(Hoxc11/
lacZ)62D9Awg [26] and kept on FVB/NTac strain back-
ground. Mice from this line were used for lacZ expression
analysis in blood vessels at postnatal and adult stages up
to 1 year of age.
Hoxa3-lacZ mice were made according to standard trans-
genic procedures using single-cell FVB/NTac embryos.
Transient transgenic mice (n = 6) and mice from one
transgenic line designated TG(Hoxa3-lacZ)184H3Awg
[26] were analyzed for reporter gene expression patterns at
embryonic stage E14.5 (2 transient) and at 11 days post
natum (p.n.) (2 transient), as well as at adult age of ≥ 6
weeks (line TG(Hoxa3-lacZ)184H3Awg, plus 2 transient
transgenic mice). Patterns observed at E14.5 were consist-
ent with the endogenous Hoxa3 expression patterns previ-
ously reported, albeit at earlier stages of embryonic
development [22-24]. Among the postnatal and adult
transient transgenic mice and the F1 mice of the
TG(Hoxa3-lacZ)184H3Awg line, the vascular expression
patterns observed at 11 days p.n. and at ≥ 6 weeks were
consistent.
X-Gal staining of lacZ reporter mouse tissue
Vascular tissues were fixed in a solution containing 0.2%
glutaraldehyde, 2% paraformaldehyde, 2 mM MgCl2 in
PBS at room temperature for periods ranging from 20
minutes to 1 hr depending on tissue. After rinsing for sev-
eral hours in detergent solution containing 2 mM MCl2,
0.02% Nonidet P-40, 0.0001% Na-deoxycholate in PBS,
the tissues were stained overnight at 32°C in a solution
containing 20 mM Tris-HCl (pH 7.3), 2 mM MgCl2,
0.02% Nonidet P-40, 0.0001% Na-deoxycholate, 20 mM
potassium-ferrocyanide, 20 mM potassium-ferricyanide,
and 0.625 mg/ml X-Gal in PBS. After rinsing in PBS,
stained tissues were fixed in 4% paraformaldehyde. For
the preparation of frozen sections, stained tissues were
infiltrated with 30% sucrose/PBS overnight at 4°C prior
to embedding in OCT compound; tissues were cryosec-
tioned and imaged using differential interference contrast
(DIC) imaging.
Reverse transcriptase (RT) – PCR
Under isoflurane anesthesia by inhalation, mouse tis-
sues were prepared by transcardial perfusion with
diluted (80%) RNAlater (Ambion, Austin, TX) to stabi-
lize vascular tissue prior to excision followed by over-
night incubation in undiluted RNAlater at 4°C. Vascular
tissues were homogenized, and RNA was isolated with
TRIzol Reagent (Invitrogen, Carlsbad, CA) according to
manufacturers instructions and subsequently treated
with RQ1 RNAse-free DNase (Promega, Madison WI).
First-strand cDNA was prepared from total RNA using
Superscript III First-Strand Synthesis System (Invitrogen,
Carlsbad, CA). Gene-specific cDNA fragments were
amplified with AmpliTaq Gold DNA Polymerase
(Applied Biosystems, Foster City, CA) using the follow-
ing primers: Hoxa3  (218 bp), F-GGGCACCGAT-
GGCGTTGAGT and R-GCTGTGGTGGGGGCTGTGGA;
Hoxc11 (311 bp), F-CCGGAGGAGGCAGGAGAAGA and
R-CCGCCGCATAACAAGACGA.  Gapdh  primers were
used for positive control reaction.
Immunofluorescence (IF) labeling/Immunohistochemistry 
(IHC)
Under isoflurane anesthesia by inhalation, 8 week old
normal FVB and TG(Hoxa3-lacZ)184H3Awg mouse tis-
sues were prepared by transcardial perfusion with 0.1 M
PIPES-buffered (pH 7.0) 2% paraformaldehyde followed
by overnight immersion of excised tissues in PIPES-buff-
ered 0.2% paraformaldehyde at 4°C. Carotid and dorsal
aorta tissues were subsequently processed for cryosection-
ing (7 μm). For IF, rabbit anti-mouse primary antibodies
for Hoxa3 (Santa Cruz Biotechnology, Santa Cruz, CA)
and smooth muscle-specific Cy3-conjugated anti-Acta2
(Smooth muscle alpha actin [SMαA] Sigma, St. Louis,
MO) were applied to carotid cross-sections at 10 μg/ml at
room temperature for 2 hours following antigen retrieval
with 10 mM Sodium Citrate (pH 6.0) buffer and brief
microwave heating. For immunolocalization, fluoro-
chrome-conjugated (Cy3 or Cy5) donkey anti-rabbit sec-
ondary antibodies (Jackson ImmunoResearch, West
Grove, PA) were used. Cell nuclei were stained with
Hoechst 33342. Fluorescence imaging at 400× was con-
ducted using a Leica DMRB HC microscope, supported by
a digital imaging workstation that includes a real time
color digital camera (SPOT-RT) and a Gateway1400 PC.BMC Developmental Biology 2008, 8:93 http://www.biomedcentral.com/1471-213X/8/93
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For immunocytofluorescence (ICF), smooth muscle cells
from dissociated vessel (see below) were immunolabeled
with primary antibodies specific for either Hoxc11, β-gal,
or Transgelin (SM22a; Abcam, Cambridge, MA) and
detected with appropriate fluorochrome secondary anti-
bodies followed by Hoechst 33342 nuclear labeling as
described above. ICF/X-Gal double-labeling was accom-
plished by labeling the fixed cells with X-Gal prior to incu-
bation with Cy3-conjugated anti-Acta2 antibodies and
Hoechst 33342.
For IHC, rabbit anti-mouse primary antibodies for Hoxa3
were applied to dorsal aorta cross-sections at 10 μg/ml at
room temperature for 2 hours following antigen retrieval
with 10 mM Sodium Citrate (pH 6.0) buffer and brief
microwave heating. Immunolocalization was detected
with Vectastain ABC Kit utilizing peroxidase-conjugated
anti-rabbit IgG antibodies and color detection with DAB,
perioxidase substrate kit (Vector Labs, Burlingame, CA)
according to manufacturers instructions. Micrographs of
DAB-labeled sections were taken with differential interfer-
ence contrast (DIC) imaging at 630×.
Vessel explant cultures – in vitro assays
Small segments (2 mm length) of the lateral marginal vein
and the femoral artery (mid-femoral region) of 6 weeks
old Hoxc11-lacZ mice were dissected and placed into col-
lagen-coated culture chambers. Explants were cultured in
M199 medium supplemented with 20% FBS and pen-
strep-glutamine. Outgrowing cells could be observed ini-
tially after ≈ 4 days, and cell density increased with pro-
longed culture.
To assess possible differential migration rates of transgene
(Hoxc11-lacZ) expressing versus non-expressing cells,
VSMCs from primary cultures were collected subsequent
to the 5th passage and plated in multi-well (4 wells) cham-
bered slides at a concentration of approximately 500 cells/
cm2 in M199 media supplemented with 20% fetal calf
serum (FCS). Cultures were allowed to grow to near con-
fluence then "scratched" with a 200 μL pipette tip produc-
ing a 0.8 mm wound traversing the length of each
chamber (2 cm). Under DIC imaging the wounded area
was defined and marked for subsequent orientation at
100×. Cultures were allowed to grow for 24 hrs prior to
processing for X-Gal labeling as described above with
minor alterations: cells were fixed for 8 min prior to labe-
ling. Using DIC imaging randomly selected fields were
chosen from scratched areas of the four experimental
wells and photographed at 100×; randomly selected fields
from "normal" un-scratched areas were likewise imaged
and photographed and used as negative controls. β-gal-
positive (blue) and -negative cells of the experimental and
control groups were scored and expressed as proportions
of total number of cells and differences expressed as -fold
change between groups. Data were expressed as mean ±
standard deviation, and statistical significance (defined as
P < 0.05) was determined using Student's t-test. For ICF
experiments, cells were dissociated by enzymatic diges-
tion (M199 media supplemented with 0.3 mg/ml elastase
type III [Sigma, St. Louis MO], 1.8 mg/ml collagenase type
I [Sigma, St. Louis MO] and 0.44 mg/ml soybean trypsin
inhibitor [Sigma, St. Louis MO]) at 37°C for 1 hr prior to
plating under the conditions as described above.
Hoxc11 Antibody Production
Custom-made, affinity-purified, chicken-anti-mouse
Hoxc11 antibodies were synthesized (Sigma Genosys, St.
Louis MO) against an epitope of the Hoxc11 protein with
the peptide sequence PPSTVTEILMKNEGS that comprises
amino acid residues 106 – 120 of the variable region of
the Hoxc11 protein; the human equivalent of this epitope
was previously used successfully for raising HOXC11 anti-
bodies [27]. Please note that the antibodies directed
against this peptide are unable to recognize the Hoxc11-
βgal fusion protein produced by the TG(Hoxc11/
lacZ)62D9Awg mice as the lacZ coding region displaces
Hoxc11 amino acids 96 – 304 in the transgene protein
product [25]. Keyhole limpet hemocyanin (KLH) was
selected as the peptide carrier protein and conjugation
was achieved through attachment to the thiol-group of an
additional cysteine residue placed at the N-terminus of
the peptide sequence. The specificity of the affinity-puri-
fied antisera was determined by ELISA, as well as immu-
nolabeling experiments with sagittal and cross sections of
E12.5 mouse embryos that yielded detection patterns very
similar to the familiar Hoxc11 RNA expression patterns
([28,29]; data not shown).
Results
Distinct Hoxc11- and Hoxa3-lacZ expression patterns in 
adult blood vessels
We previously reported that transgenic mice (n = 4 found-
ers) carrying a Hoxc11-lacZ  reporter gene construct in
which E.coli lacZ with SV40 RNA processing signals was
fused in-frame to Hoxc11 exon 1 coding sequences exhib-
ited a conspicuous and reproducible β-gal expression pat-
tern in mid-gestation embryos at ≈ E12 [25]. This pattern
(Fig. 1A) was consistent with the posteriorly restricted pat-
tern of endogenous Hoxc11 expression in par-axial and
hindlimb mesenchyme as determined by ISH [25,28,29].
Accordingly, we concluded that this Hoxc11-lacZ construct
included most of the control elements required for estab-
lishing the native Hoxc11 expression pattern in mid-gesta-
tion embryos [25,28,29]. Here, we used one of these
Hoxc11-lacZ transgenic lines as a tool for gaining insight
into global aspects of Hoxc11 expression during fetal and
postnatal development, as well as in adulthood. This
revealed β-gal activity in the hindlimb vasculature that
had previously escaped our attention. Examination ofBMC Developmental Biology 2008, 8:93 http://www.biomedcentral.com/1471-213X/8/93
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young adult transgenic mice showed lacZ expression (X-
Gal labeling) in all major blood vessels of the hindlimb,
including arteries and veins (Fig. 1D–F) with strongest
expression at the level of the zeugopod and lower stylo-
pod (femur). In several vessels, including the femoral
artery, X-Gal labeling was rather uniform in the lower
limb and became progressively mosaic in upper femoral
limb regions near the expression boundary (Fig. 1E, F).
However, vessels showing mosaic β-gal expression pat-
terns could also be seen next to vessels that appeared to be
uniformly stained at a given proximal-distal level of the
zeugopod. Persistent vascular expression was observed in
animals of 1 year of age (Fig. 1G), the latest stage exam-
ined.
In addition to expression in blood vessels, we observed
strong and specific Hoxc11-lacZ activity in kidney, ureter,
urinary bladder, and uterus (data not shown). This activ-
ity in both the male and female urogenital system is con-
sistent with previously reported endogenous Hoxc11
expression in the metanephric mesenchyme during mid-
gestation, and in cortical regions of the developing kidney
during later development [28], as well as HOXC11 expres-
sion in human uterine endometrium [30]. Furthermore,
we also observed diffuse β-gal activity in hindlimb carti-
lage and skeletal muscle of postnatal and adult mice (Fig.
1B, C, E); although this activity apparently became gradu-
ally weaker and increasingly restricted to distal limb
regions with age, it was still clearly detectable in 1 year old
mice (Fig. 1G). This may indicate that endogenous
Hoxc11  expression in skeletal muscle, first observed in
embryonic myotomes and developing muscle during fetal
development [28], persists in adulthood.
To gain further support for the emerging concept of dis-
tinct zones of Hox activity in the adult vascular network,
we prepared a Hoxa3-lacZ transgene construct that con-
tained 11.5 kb of genomic sequences located directly
upstream of the Hoxa3 translational start site (see Materi-
als and Methods). Analysis of independent Hoxa3-lacZ
transgenic mice (n = 4) at 11 d, 6 wks, and ≥ 8 wks post
natum revealed a reproducible pattern of lacZ expression
in most major blood vessels (common carotid arteries,
aortic arch, dorsal aorta and inter-costal arteries, pulmo-
nary and renal arteries, cardinal and jugular veins, proxi-
mal femoral arteries and veins) (Fig. 2A–E). Remarkably,
the distinct anterior expression boundary near the cranial
branch point of the common carotid arteries (Fig. 2E) was
approximately at the same anterior-posterior level as the
expression boundary in the jugular veins (Fig. 2A), and
these expression boundaries roughly correspond to the
anterior Hoxa3 expression limit at the somite s4/5 bound-
ary during embryonic development [22]. Hoxa3-lacZ
expression in the dorsal aorta and inferior vena cava
extended beyond the iliac branching point into the most
caudal blood vessels of the tail, as well as the proximal
limb vessels, including expression in the proximal seg-
ments of the femoral artery and vein that reached just to
the branch of the epigastric artery (Fig. 2D).
To determine reporter gene expression patterns in vessel
walls, we analyzed sections of X-Gal-stained blood vessels
Analysis of Hoxc11-lacZ reporter gene expression in hindlimb vasculature Figure 1
Analysis of Hoxc11-lacZ reporter gene expression in hindlimb vasculature. (A) E12 embryo of the transgenic shows 
posteriorly restricted lacZ reporter gene expression (blue) in most of the hindlimb region and tailbud, as well as in the poste-
rior zeugopodal forelimb region. (B) X-Gal staining of posterior trunk and hindlimbs of 0.5 d newborn Hoxc11-lacZ transgenic 
mouse after skinning reveals expression in skeletal muscles and blood vessels (yellow arrow). (C) Lateral view of stained hind-
limb of 42 d Hoxc11-lacZ transgenic mouse shows conspicuous β-gal activity in sciatic artery. (D-F) Medial view of same hind-
limb as shown in panel C is presented in panel E and reveals distally restricted expression in both arteries and veins; close-up 
views of upper and lower sections of femoral artery (red arrows) and vein (blue arrows) are shown in panels D and F, respec-
tively. (G) Lateral view of stained hindlimb from 1 yr old Hoxc11-lacZ transgenic mouse shows persistent reporter gene expres-
sion in blood vessels, most prominently in sciatic artery. All mice were derived from transgenic line TG(Hoxc11-
lacZ)62D9Awg; fl: forelimb; hl: hindlimb; tlb: tailbud.BMC Developmental Biology 2008, 8:93 http://www.biomedcentral.com/1471-213X/8/93
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from adult Hoxc11-lacZ and Hoxa3-lacZ mice (≥ 6 wks). As
exemplified by data shown in Figure 3, Hoxc11-lacZ
expression was observed predominantly, if not exclu-
sively, in subsets of VSMCs of the major blood vessels of
the lower hindlimb, including arteries (Fig. 3A) and veins
(Fig. 3B). Overall, the Hoxa3-lacZ-expressing vessel walls
of the iliac artery, the descending thoracic aorta, the inter-
costal arteries, and the common carotid arteries (Fig. 3C–
F) exhibited similar patterns as the Hoxc11-lacZ-express-
ing walls of the lower limb, including prominent expres-
sion in VSMCs. Due to their flat morphology, expression
in epithelial cells lining the intimal lamina was difficult to
discern based on X-Gal staining in either case (i.e. Hoxc11-
lacZ and Hoxa3-lacZ transgenic mice). This was resolved
by performing immunofluorescent labeling studies using
β-gal-specific antibodies, which detected endothelial β-gal
expression in the common carotids of Hoxa3-lacZ mice,
but not in the tibial/femoral arteries of Hoxc11-lacZ mice
(data not shown).
Validation of Hoxc11 and Hoxa3 reporter gene 
expression patterns
To determine whether the vascular Hoxc11- and Hoxa3-
lacZ  reporter gene expression reflected corresponding
endogenous gene activities, we performed semi-quantita-
tive reverse transcriptase (RT)-PCR analysis of total RNA
isolated from defined vessel segments of 6 wk old mice.
For a first set of reactions, we used RNA isolated from fem-
oral artery and vein segments ranging from the mid-fem-
oral region just proximal to the Hoxc11-lacZ expression
boundary to the distal femoral artery branch point
approximately at knee-level. In addition to examining this
RNA sample for the presence of Hoxc11-specific tran-
scripts, we determined whether there was evidence for
expression of the remaining AbdB-type Hoxc genes (Hoxc9,
Hoxc10, Hoxc12, and Hoxc13), as well as for the Hoxc11
and  Hoxc10  paralogous genes (Hoxa11, Hoxd11, and
Hoxa10, Hoxd10). The results indicate strong expression of
Hoxc11 and Hoxc10, whereas Hoxc9 expression appeared
less abundant, and expression of Hoxc12 and Hoxc13 was
not detectable (Fig. 4A). Strong expression was also indi-
cated for two of the paralogous genes, Hoxa11  and
Hoxd10, whereas no RT-PCR amplification product was
detected for Hoxa10, and the band corresponding to
Hoxd11 was weak (Fig. 4A). These data suggest selective
activity of AbdB-type Hoxc genes in major blood vessels of
the mid-femoral hindlimb region. Specifically, the detec-
tion of Hoxc11-specific amplification products suggests
that the vascular Hoxc11-lacZ  reporter gene expression
observed in this region reflects authentic Hoxc11  tran-
Hoxa3-lacZ expression in major blood vessels Figure 2
Hoxa3-lacZ expression in major blood vessels. (A-E) Prominent expression (blue) was detected by whole-mount X-Gal 
staining of 6 wk old Hoxa3-lacZ transgenic mice in external jugular vein (panel A), aortic arch (AA) and all major vessels in the 
aortic arch region including innominate and left carotid artery, pulmonary vein (PA), and subclavian artery (panel B); strong 
expression was also detected in the descending thoracic aorta (DA) and intercostal arteries (panel C), as well as the common 
iliac artery and proximal femoral artery (panel D); Hoxa3-lacZ expression in the common carotid artery exhibits a distinct ante-
rior boundary near the branch point into facial and occipital carotid arteries (panel E); anterior points to the top in panels A-C, 
and E, and to the right in panel D; please note the distal expression boundary in the femoral artery just below the branch point 
of the internal iliac. LA: left atrium; LV: left ventricle; RA: right atrium; thy: thyroid gland.BMC Developmental Biology 2008, 8:93 http://www.biomedcentral.com/1471-213X/8/93
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scriptional activity. The detection of Hoxa11- and Hoxc9-
specific amplification products is consistent with the isola-
tion of HOXA11 and HOXC9 cDNAs from human smooth
muscle cell cDNA libraries reported previously [18].
To obtain supporting evidence for regionally restricted
expression of endogenous Hoxa3 and Hoxc11 within the
vascular network, we isolated RNA from the aortic arch,
the descending thoracic aorta, and the distal femoral
artery (the distal femoral artery segment used was as
defined above) for RT-PCR analysis. In agreement with
the Hoxa3- and Hoxc11-lacZ reporter gene analysis, the
data indicate Hoxa3 expression in the aortic arch and the
descending thoracic aorta but not in the distal femoral
artery, whereas Hoxc11 expression is detectable exclusively
in the latter (Fig. 4B).
Evidence that the anterior Hoxa3-lacZ boundary in carotid
arteries (Fig. 2E) reflects the endogenous Hoxa3 pattern in
these vessels was provided at the protein level by immu-
nolabeling studies with Hoxa3-specific antibodies that
detected Hoxa3 protein exclusively in sections of carotid
vessel segments located posterior of this boundary (Fig.
5). Furthermore, while Hoxa3-lacZ  expression in the
endothelial layer was difficult to discern by X-Gal staining
as exemplified in Figure 6A, endogenous Hoxa3 protein
expression in both ECs and VSMCs of the aortic arch was
confirmed by immunolabeling (Fig. 6B,C). Combined,
these data strongly suggest that Hoxa3-lacZ mimics the
authentic Hoxa3 expression pattern in adult blood vessels.
The Hoxa3-lacZ patterns correlate remarkably well with
the broad spectrum of vascular defects previously
observed in Hoxa3 null mice, which included abnormali-
ties of the carotid system, thinning of the aorta and
enlargement of major veins [4,6]. Lack of information
about the Hoxa3  vascular expression pattern, however,
largely precluded interpretation of these data with regard
to potential underlying mechanisms.
Hoxc11-lacZ expression ex vivo
Blood vessel explants (segments of ≈ 2 mm length) of the
lateral marginal vein and the distal femoral artery of 6 wk
old Hoxc11-lacZ mice were cultured to determine whether
reporter gene activity was retained in outgrowing cells.
Initial outgrowth was observed after ≈ 4 days under stand-
ard conditions (M199 medium supplemented with 20%
FBS and pen-strep glutamine; see Materials and Methods),
and X-Gal staining after 11 days of culture consistently
Hoxc11- and Hoxa3-lacZ expression patterns in blood vessel sections of 6 wk old transgenic mice Figure 3
Hoxc11- and Hoxa3-lacZ expression patterns in blood vessel sections of 6 wk old transgenic mice. (A, B) Cross 
sections of the distal femoral artery (panel A) and femoral vein (B) show restriction of Hoxc11-lacZ expression in subsets of 
VSMCs in arterial and venous vessel walls as indicated by X-Gal staining (blue). (C-F) Cross sections of X-Gal-stained iliac 
artery (C), descending thoracic aorta (D), intercostal artery (E), and common carotid artery (F) of Hoxa3-lacZ transgenic mice 
indicate strong β-gal expression (blue) in the VSMCs of the vessel walls, whereas X-Gal staining in the flattened endothelial 
cells lining the intimal laminae is difficult to discern. adv: adventitia eem: external elastic membrane, iem: internal elastic mem-
brane, in: intima, m: media. Space bars: 25 μm in all panels.BMC Developmental Biology 2008, 8:93 http://www.biomedcentral.com/1471-213X/8/93
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showed β-gal activity in a fraction of the outgrowing cells
(Fig. 7A, B), while control explants from corresponding
regions of non-transgenic mice did not produce β-gal-pos-
itive cells (not shown). Co-labeling with antibodies
directed against a common marker for smooth muscle
cells (SMCs), i.e. Acta2 (previously known as SMαA)
showed that the β-gal-positive cells expressed Acta2,
whereas not all of the Acta2-expressing cells were β-gal-
positive (compare panels B and B' in Fig. 7). Using
Hoxc11- and β-gal-specific antibodies (see Materials and
Methods for preparation and testing of Hoxc11-specific
antibodies) in double-immunolabeling studies, we deter-
mined that these β-gal-positive cells do express endog-
enous Hoxc11 (Fig. 7C,C',C"). Furthermore, using the
Hoxc11 antibodies in double-immunolabeling assays
with Acta2 antibodies, as well as antibodies against a sec-
ond SMC marker, Transgelin (Tagln; previously known as
SM22) showed co-labeling in the perinuclear region of
individual cultured VSMCs from the femoral artery of
TG(Hoxc11/lacZ)62D9Awg mice in both cases (Fig.
7D,E).
Continued Hoxc11-lacZ expression in only a subpopula-
tion of cultured VSMCs raised the question whether these
cells might be functionally distinct compared to β-gal-
negative cells. This was addressed in a preliminary man-
ner by performing two simple and straightforward in vitro
assays that tested response to culture serum levels and
migration behavior. The results show that the proportion
of Hoxc11-lacZ-expressing cells increased approximately
3-fold to 13.5% under serum-free culture conditions com-
pared to about 4.3% under conditions including 20% FBS
(Fig. 8A). In scratch assays, the proportion of β-gal-posi-
tive cells was dramatically reduced (71-fold) among the
migratory cells found in the scratch area compared to the
cells residing in the undisturbed monolayer (Fig. 8B).
These differential reporter gene expression patterns in cul-
tured VSMCs undergoing phenotypic modulation suggest
that Hoxc11 expression is associated with distinct VSMC
phenotypes.
VSMCs are capable of exhibiting a wide range of different
phenotypes in response to changes in local environmental
cues, a phenomenon known as phenotypic modulation or
phenotype switching [31,32]. The morphologically and
functionally distinct synthetic and contractile VSMCs are
considered to mark the boundaries at the opposite ends of
a spectrum within which VSMCs can modulate their phe-
notypic properties [33]. The decreased Hoxc11-lacZ
expression in migrating cells is consistent with the lower
level of reporter gene activity in response to serum – in
both cases the phenotypic equilibrium is shifted towards
a proliferative and synthetic phenotype [32]. Accordingly,
these data suggest preferential Hoxc11 activity in contrac-
tile VSMCs of spindle-like morphology.
Discussion
During development, a primary role of Hox  genes is
thought to "translate" positional information established
within a spatial coordinate system into positional identi-
RT-PCR analysis of Hox gene expression in adult blood vessels Figure 4
RT-PCR analysis of Hox gene expression in adult blood vessels. (A) Total RNA derived from hindlimb blood vessels (6 
wk old FVB/NTac mice) as defined in the text was used for cDNA synthesis, and Hox-specific cDNA fragments were amplified 
by using primers specific for the AbdB-type Hoxc genes; this resulted in PCR products in the expected size range for Hoxc9 (323 
bp), Hoxc10 (350 bp), and Hoxc11 (435 bp); PCR reactions with primers specific for the Hoxc11 and Hoxc10 paralogous genes 
(Hoxa11 and Hoxd11, as well as Hoxa10 and Hoxd10) resulted in amplification products in the expected size range for Hoxa11 
(220 bp), Hoxd11 (131 bp), and Hoxd10 (286 bp), whereas no product was detected for Hoxa10; positive control reaction: 
Gapdh-specific primers; MW: molecular weight standards in base pairs (bp). (B) RT-PCR analysis of Hoxa3 and Hoxc11 expres-
sion in adult mouse (6 wk) blood vessel segments including aortic arch (AA), descending thoracic aorta (DA), and distal femo-
ral artery (dFA); positive control reaction was performed with β-actin-specific primers.BMC Developmental Biology 2008, 8:93 http://www.biomedcentral.com/1471-213X/8/93
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ties, which is essential for the differentiation of defined
body structures at their appropriate anatomic sites [34].
Once adult structures and organs have formed, a funda-
mental question arises regarding how their organo-typic
shape and physiological properties are being maintained.
According to a recently proposed concept this may be
achieved by retaining positional identities specified by a
Hox code [35,36], which is initially set up during embry-
onic patterning [37]. This positional identity model was
supported by gene expression profiling of human fibrob-
last populations derived from distinct adult anatomic
sites, which revealed that the site-specific Hox profiles mir-
rored the embryonic Hox  patterns relative to the main
developmental axes. This was interpreted as evidence for
a Hox code-based positional memory underlying the con-
trol of topographic fibroblast differentiation [35,36]. The
results presented here show complex, yet distinct, spa-
tially restricted Hoxa3 and Hoxc11 patterns in adult blood
vessels (see Fig. 9 for a schematic summary) that largely
correspond to the embryonic Hoxa3 [23,24] and Hoxc11
[25,28] activity domains. These data are consistent with
the positional identity model and support the idea of dis-
crete Hox-specified identities in the vascular network. Val-
idation of this concept in future studies will require a
comprehensive analysis of the spatial expression patterns
of all 39 Hox genes in the developing and adult cardiovas-
cular system.
In keeping with the positional identity model, recent glo-
bal gene expression profiling revealed that similar to
fibroblasts, ECs and SMCs exhibit considerable diversity
depending on function and anatomic site [38,39]. Within
the cardiovascular system, this is likely to reflect diverse
physiological requirements, including regional variations
in vessel tone, blood flow, blood pressure, oxygen con-
tent, nutrient content, etc., and Hox genes are considered
excellent candidates for orchestrating the corresponding
regional gene expression profiles [3,38,39]. Data demon-
strating that genes encoding SMC-restricted proteins are
direct targets of Hox transcription factors [40] are consist-
ent with this model. Furthermore, several Hox  genes
(including Hoxa3) have been implicated in controlling
the conversion of ECs to the angiogenic phenotype [41],
which is of great relevance for tumor-angiogenesis, as well
as for neo-vascularization during wound healing and
other normal adult physiological activities. Likewise, phe-
notype switching of VSMCs is known to be associated
with a wide range of diseases of the cardiovascular system
including atherosclerosis, stroke, high blood pressure,
aneurisms, etc. [32]. Our data showing Hoxc11 expression
Validation of endogenous Hoxa3 expression boundary in adult carotid artery of FVB/NTac mouse Figure 5
Validation of endogenous Hoxa3 expression boundary in adult carotid artery of FVB/NTac mouse. (A) Diagram 
of right carotid segment indicating reporter gene expression domain (blue shading) with anterior boundary at level of lingual 
artery (la) as observed in Hoxa3-lacZ transgenic mouse (see Fig. 2E for comparison); yellow arrow points to carotid bifurcation 
into internal (ica) and external carotid arteries (eca), respectively; sections corresponding to levels L1 and L2 as indicated in 
the cartoon were used for detection of Hoxa3 and Acta2 by immunofluorescence as shown in the three upper (B,B'B") and 
lower (C,C',C") panels to the right. Both L1 and L2 sections were incubated with Hoxa3-specific and Cy3-conjugated Acta2-
specific antibodies; using Cy5-conjugated secondary antibodies, red-fluoresent-labeled Hoxa3 protein was detected only in sec-
tion L2 (panel C'), whereas green-fluorescent-labeled Acta2 expressed in VSMCs was detected in both L1 and L2 sections 
(panels B" and C"); accordingly, multichannel composite micrographs (panels B and C) for detecting red (Cy5), green (Cy3) and 
blue (Hoechst 33342 for nuclear labeling; this is not shown individually) indicate co-localization of Hoxa3 and Acta2 (yellow) in 
VSMCs only in section L2 (panel C). fa: facial artery; oa: occipital artery.BMC Developmental Biology 2008, 8:93 http://www.biomedcentral.com/1471-213X/8/93
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to be restricted to a subset of VSMCs derived from the
same vessel and anatomic site as VSMCs not expressing
Hoxc11 may indicate that Hox expression profiles are asso-
ciated with distinct VSMC phenotypes. This proposition is
further underscored by the preliminary results from our
functional assays suggesting a role for Hoxc11 in defining
phenotypic properties of VSMCs. Taken together, eluci-
dating the role of Hox genes in adult blood vessels is likely
to be critically important for understanding vascular dis-
ease mechanisms.
Conclusion
Our results support a conceptual model of Hox-specified
positional identities in adult blood vessels, which is of
likely relevance for understanding the mechanisms under-
lying regional physiological diversities in the cardiovascu-
lar system. The data also demonstrate that conventional
Hox reporter gene mice are useful tools for visualizing
complex Hox expression patterns in the vascular network
that might be unattainable otherwise. Importantly, these
mice are a valuable resource for the isolation and pheno-
typic characterization of specific subpopulations of vascu-
lar cells marked by distinct Hox expression profiles.
Comparison of Hoxa3-lacZ reporter and endogenous Hoxa3  protein expression in VSMCs and ECs of aortic arch Figure 6
Comparison of Hoxa3-lacZ reporter and endogenous 
Hoxa3 protein expression in VSMCs and ECs of aor-
tic arch. (A) Cross section of aortic arch from adult Hoxa3-
lacZ mouse after X-Gal-staining indicates reporter gene 
expression (blue) in VSMCs (yellow arrows) whereas expres-
sion in cells of the endothelial layer (gray arrows) is difficult 
to discern. (B) Immunohistochemical detection of Hoxa3 in 
comparable section of adult (8 wk) dorsal aorta; immunola-
beling of section with anti-Hoxa3 antibodies and subsequent 
colorimetric detection (DAB-Ni) reveals expression in ECs 
(gray arrows) and vascular VSMC (yellow arrows). (C) Mul-
tichannel composite micrograph of adult aortic arch section 
after incubation with immunoreagents specific for Hoxa3 
(Cy5-red) and Acta2 (Cy3- green), and Hoechst 33342 for 
nuclear labeling. The bright red labeling in ECs (gray arrows) 
confirms Hoxa3 expression. The purple labeling in the media 
indicates Hoxa3 expression in certain nuclei of VSMCs (yel-
low arrows). Green label indicates that Acta2 expression is 
restricted to the media. Lumen is to the left in all panels; 
space bar: 25 μm.
Hoxc11-lacZ expression is restricted to a subset of smooth  muscle cells in vessel explant culture Figure 7
Hoxc11-lacZ expression is restricted to a subset of 
smooth muscle cells in vessel explant culture. (A) Cel-
lular outgrowth of explanted femoral artery/lateral marginal 
vein vessel segments (~2 mm; central dark ovoid structure in 
panel A) from young adult Hoxc11-lacZ transgenic mice 
[TG(Hoxc11/lacZ)62D9Awg] is comprised of β-gal-positive 
(blue) and -negative cells (black arrows in panel A, inset). (B) 
X-Gal labeling of cultured, femoral artery SMCs of Hoxc11-
lacZ reporter mice reveals β-gal-positive (blue) and β-gal-
negative cells as indicated by grey and white arrows, respec-
tively. (B') Subsequent to X-Gal labeling, the cells shown in 
panel B were immunolabeled with antibodies specific for 
SMC marker Acta2 (formerly known as SMαA) as indicated 
by green fluorescence; note that both β-gal-positive and -
negative cells as marked by grey and white arrows, respec-
tively (grey and white arrows correspond to the same cells in 
panels B and B'), are labeled by anti-Acta2; nuclei were 
labeled with Hoechst 33342 (blue). (C/C'/C") Double-labe-
ling of explant-derived, cultured femoral artery SMCs of 
TG(Hoxc11/lacZ)62D9Awg mice with antibodies against 
Hoxc11 (red signal, panel C) and anti-β-gal (green signal, 
panel C') results in a merged yellow signal in panel C". (D/E) 
Double-immunolabeling of cultured mitotic femoral artery 
SMCs with antibodies against Hoxc11 (red signal) and two 
standard SMC markers, including Transgelin (Tagln, formerly 
known as Smooth muscle protein 22-alpha; green signal, 
panel D), and Acta2 (green signal, panel E); note, overlap 
between Hoxc11 and Tagln signals in panel D results in yel-
low fluorescence, whereas the lesser degree of overlap 
between Hoxc11 and Acta2 signals in panel E results in dis-
cernible Hoxc11 (red) signal in the peri-nuclear region. 
Nuclei (blue) were labeled with Hoechst 33342.BMC Developmental Biology 2008, 8:93 http://www.biomedcentral.com/1471-213X/8/93
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